Company Accounts and Tax Online 12984531 Board of Directors 6.4.24 28.10.24 28.10.24 No description of principal activity false iso4217:GBP xbrli:pure 12984531 2023-04-06 2024-04-05 12984531 2024-10-28 12984531 2024-04-06 2024-10-28 12984531 2024-04-05 12984531 countries:EnglandWales 2024-04-06 2024-10-28 12984531 curr:PoundSterling 2024-04-06 2024-10-28 12984531 uk-bus:PrivateLimitedCompanyLtd 2024-04-06 2024-10-28 12984531 uk-bus:Micro-entities 2024-04-06 2024-10-28 12984531 uk-bus:AuditExempt-NoAccountantsReport 2024-04-06 2024-10-28 12984531 uk-bus:FullAccounts 2024-04-06 2024-10-28 12984531 uk-bus:RegisteredOffice 2024-04-06 2024-10-28 12984531 uk-bus:Director1 2024-04-06 2024-10-28 12984531 uk-bus:Director1 2024-04-06 12984531 uk-bus:Director1 2024-10-28 12984531 core:AfterOneYear 2024-10-28 12984531 core:AfterOneYear 2024-04-05 12984531 core:WithinOneYear 2024-10-28 12984531 core:WithinOneYear 2024-04-05 12984531 core:WithinOneYear 2024-04-06 2024-10-28 12984531 core:AfterOneYear 2024-10-28 12984531 core:AfterOneYear 2024-04-05 12984531 core:AfterOneYear 2024-04-06 2024-10-28 12984531 core:ShareCapital 2024-10-28 12984531 core:ShareCapital 2024-04-05 12984531 core:RevaluationReserve 2024-10-28 12984531 core:RevaluationReserve 2024-04-05 12984531 core:RetainedEarningsAccumulatedLosses 2024-10-28 12984531 core:RetainedEarningsAccumulatedLosses 2024-04-05 12984531 1 2024-04-06 2024-10-28

# BAIDEX PHARMA LTD

## Company Registration Number:
12984531 (England and Wales)

## Unaudited micro entity accounts for the year ended 28 October 2024

## Period of accounts

## Start date: 06 April 2024

## End date: 28 October 2024

# BAIDEX PHARMA LTD

## Contents of the Financial Statements

for the Period Ended 28 October 2024

Company Information - 3 |
Balance sheet - 4 |
Footnotes to the Balance Sheet - 6 |

# BAIDEX PHARMA LTD

## Company Information

for the Period Ended 28 October 2024

Registered office: |  | Unit 37, Spaces Business Centre Knight Road Strood Rochester Kent England ME2 2BF
Company Registration Number: |  | 12984531 (England and Wales)

# BAIDEX PHARMA LTD

## Balance sheet

As at 28 October 2024

| 7 months to 28 Oct 2024 £ | 2024 £
--- | --- | ---
Called up share capital not paid: |  | 0
Fixed Assets: | 94,200 | 64,519
Current assets: | 3,869,610 | 1,448,200
Creditors: amounts falling due within one year: | ( 1,735,000 ) | ( 696,200 )
Net current assets (liabilities): | 2,134,610 | 752,000
Total assets less current liabilities: | 2,228,810 | 816,519
Creditors: amounts falling due after more than one year: | ( 0 ) | ( 0 )
Provision for liabilities: | ( 75,000 ) | ( 0 )
Total net assets (liabilities): | 2,153,810 | 816,519
Capital and reserves: | 2,153,810 | 816,519

# BAIDEX PHARMA LTD

## Balance sheet continued

For the year ending 28 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 29 October 2024
And Signed On Behalf Of The Board By:

Name: KWASI BAIDEN
Status: Director

The notes form part of these financial statements

# BAIDEX PHARMA LTD

## Footnotes to the Financial Statements

for the Period Ended 28 October 2024

- ## 1. Employee Information

  Average number of employees: 5

# BAIDEX PHARMA LTD

## Footnotes to the Financial Statements

for the Period Ended 28 October 2024

- ## 2. Off balance sheet disclosure

  No